ArticleBiophotonics discovery2026
Advancing subclinical keratoconus detection using polarization-sensitive optical coherence tomography and artificial intelligence.
Article in Biophotonics discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Early detection of keratoconus (KC), a progressive corneal disorder, remains a major clinical challenge. Polarization-sensitive optical coherence tomography (PS-OCT) is an advanced imaging technique that can quantify corneal birefringence, offering insight into collagen organization and microstructural integrity. Approach: A total of 359 eyes were examined and evaluated. This study explores PS-OCT-derived phase retardation (PR) and corneal sublayer thickness as potential diagnostic biomarkers for healthy, subclinical (SKC), and KC eyes. Further, the performance of AI-based classification models developed from PS-OCT, Pentacam, and MS-39 data were compared, using random forest classifier trained with a leave-one-out methodology and identical hyperparameter settings. Results: All AI models demonstrated comparable accuracy among devices for healthy and KC detection. However, SKC classification differed from Pentacam and MS-39. Here, 39.5% of the SKC eyes were reclassified as healthy by PS-OCT, compared with 27.5% by Pentacam and 30.3% by MS-39. The average diagnostic performance of PS-OCT included an AUC, precision, recall, F1 score, and accuracy of 0.91, 83%, 82%, 0.82, and 82%, respectively. For the Pentacam, the same were 0.95, 87%, 86%, 0.86, and 86%, respectively. For the MS-39, the same were 0.94, 86%, 86%, 0.85, and 86%, respectively. Conclusions: Overall, AI model agreement was strong for healthy and KC groups but varied in SKC. PS-OCT provides complementary diagnostic value and may refine subclinical KC detection for safer refractive surgery decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.